Worldwide, the incidence of<unk> -hydroxylase deficiency, classic type (salt wasting) is 5 per 100,000 persons. Prevalence varies according to ethnicity and geographic area and ranges from a low of 3.57 per 100,000 persons in Chinese population to a high of 357 per 100,000 persons in Yupik Eskimos in Alaska. This disease usually affects Ashkenazi Jews and individuals of the Mediterranean race. The classic type affects approximately 6.25 in 100,000 live births. Non-classic type is one of the most common autosomal recessive disorders in humans and affects approximately 100 in 100,000 individuals, but among inbred populations, such as Eastern European (Ashkenazi) Jews the prevalence may reach up to 1000 per 100,000 individuals. Incidence for<unk> -hydroxylase deficiency is higher in some ethnic groups, particularly in remote geographic regions such as Alaskan Yupiks.
21-hydroxylase deficiency epidemiology and demographics
17 alpha-hydroxylase deficiency epidemiology and demographics
11β-hydroxylase deficiency epidemiology and demographics
17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics
17 alpha-hydroxylase deficiency classification
21-hydroxylase deficiency classification
21-hydroxylase deficiency laboratory findings
17 alpha-hydroxylase deficiency medical therapy